← Open Payments lookup

JUNNESH MOUSHI: Open Payments

NPI 1083395966 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$579 in 29 payments from 14 companies in 2025. Trend: 2023 $308 · 2024 $624 · 2025 $579

Food & beverage: $579
CompanyPaymentsAmount
Novo Nordisk Inc7$135
ABBVIE INC.4$81
PFIZER INC.4$79
Boston Scientific Corporation1$49
Lilly USA, LLC3$42
GlaxoSmithKline, LLC.2$33
Inspire Medical Systems, Inc.1$31
Edwards Lifesciences Corporation1$24
Abbott Laboratories1$21
Exact Sciences Corporation1$20

Products named: Ozempic, PREVNAR 20, General - Therapies, QULIPTA, VRAYLAR, INSPIRE, MOUNJARO, SAPIEN 3 Ultra RESILIA.

Industry payments across AZ — which companies pay providers there.